NuCana

Clinical-stage biopharmaceutical company developing next-generation cancer medicines using its proprietary ProTide technology to deliver nucleotide analogs more effectively to cancer cells.

Location
Edinburgh, United Kingdom
Founded
2008
Investors
1
Categories
oncology, cancer-therapeutics, biotech, prodrug-technology

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34